Kinnate Biopharma Inc. Cash on Hand 2021-2023 | KNTE
Kinnate Biopharma Inc. cash on hand from 2021 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Kinnate Biopharma Inc. Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $154 |
| 2022 | $227 |
| 2021 | $253 |
| 2020 | $397 |
| 2019 | $76 |
| 2018 | $7 |
| Kinnate Biopharma Inc. Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2023-12-31 | $154 |
| 2023-09-30 | $168 |
| 2023-06-30 | $185 |
| 2023-03-31 | $201 |
| 2022-12-31 | $227 |
| 2022-09-30 | $257 |
| 2022-06-30 | $262 |
| 2022-03-31 | $270 |
| 2021-12-31 | $253 |
| 2021-09-30 | $258 |
| 2021-06-30 | $255 |
| 2021-03-31 | $248 |
| 2020-12-31 | $397 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
